指南与共识耳科与耳神经

临床实践指南(更新版):耵聍栓塞

Clinical Practice Guideline (Update): Earwax (Cerumen Impaction).
指南 / 共识 · Otolaryngol Head Neck Surg · 2017-01-01

本指南为2008年美国耳鼻咽喉头颈外科学会耵聍栓塞临床实践指南的更新版,基于新证据(3部指南、5项系统评价、6项随机对照试验)提供循证推荐。指南定义了耵聍栓塞,新增3条关键行动声明(一级预防、禁忌干预、转诊与协调照护),并强调特殊人群和管理修正因素。

要点

  • 强烈推荐:对伴有症状或妨碍耳部评估的耵聍栓塞应治疗或转诊。
  • 推荐:无症状且耳部可充分检查者不应常规处理耵聍。
  • 推荐:反对使用耳烛治疗或预防耵聍栓塞。

核心结论

  • 指南旨在帮助临床医生识别可能从干预中获益的耵聍栓塞患者,并促进循证管理。

研究设计与样本

  • 美国耳鼻咽喉头颈外科学会基金会更新2008年耵聍栓塞临床实践指南,纳入新证据(3部指南、5项系统评价、6项随机对照试验)。

主要发现

  • 与旧版相比,更新包括:消费者加入制定组、新证据、患者教育信息增强、新算法、行动声明概要扩展、外部评审增强及3条新关键行动声明。

关键数值与推荐

  • 强烈推荐:临床医生应治疗或转诊可治疗耵聍栓塞(耵聍积聚伴症状或妨碍必要耳部评估)。
  • 推荐:临床医生应向耵聍积聚患者解释正确耳部卫生以预防耵聍栓塞。
  • 推荐:临床医生应根据耳镜检查发现耵聍积聚伴症状或妨碍必要耳部评估来诊断耵聍栓塞。
  • 推荐:临床医生应通过病史和/或体格检查评估影响管理的因素,如抗凝治疗、免疫抑制状态、糖尿病、头颈部放疗史、耳道狭窄、骨疣、鼓膜不完整。
  • 推荐:临床医生不应常规治疗无症状且耳部可充分检查的耵聍。

临床怎么用

  • 临床医生应识别并治疗或转诊伴有症状或妨碍耳部评估的耵聍栓塞患者。
  • 对无症状且耳部可充分检查者,不应常规处理耵聍。
  • 治疗选项包括耵聍溶解剂、冲洗或器械手动取出,可单独或联合使用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective This update of the 2008 American Academy of Otolaryngology-Head and Neck Surgery Foundation cerumen impaction clinical practice guideline provides evidence-based recommendations on managing cerumen impaction. Cerumen impaction is defined as an accumulation of cerumen that causes symptoms, prevents assessment of the ear, or both. Changes from the prior guideline include a consumer added to the development group; new evidence (3 guidelines, 5 systematic reviews, and 6 randomized controlled trials); enhanced information on patient education and counseling; a new algorithm to clarify action statement relationships; expanded action statement profiles to explicitly state quality improvement opportunities, confidence in the evidence, intentional vagueness, and differences of opinion; an enhanced external review process to include public comment and journal peer review; and 3 new key action statements on managing cerumen impaction that focus on primary prevention, contraindicated intervention, and referral and coordination of care. Purpose The primary purpose of this guideline is to help clinicians identify patients with cerumen impaction who may benefit from intervention and to promote evidence-based management. Another purpose of the guideline is to highlight needs and management options in special populations or in patients who have modifying factors. The guideline is intended for all clinicians who are likely to diagnose and manage patients with cerumen impaction, and it applies to any setting in which cerumen impaction would be identified, monitored, or managed. The guideline does not apply to patients with cerumen impaction associated with the following conditions: dermatologic diseases of the ear canal; recurrent otitis externa; keratosis obturans; prior radiation therapy affecting the ear; previous tympanoplasty/myringoplasty, canal wall down mastoidectomy, or other surgery affecting the ear canal. Key Action Statements The panel made a strong recommendation that clinicians should treat, or refer to a clinician who can treat, cerumen impaction, defined as an accumulation of cerumen that is associated with symptoms, prevents needed assessment of the ear, or both. The panel made the following recommendations: (1) Clinicians should explain proper ear hygiene to prevent cerumen impaction when patients have an accumulation of cerumen. (2) Clinicians should diagnose cerumen impaction when an accumulation of cerumen, as seen on otoscopy, is associated with symptoms, prevents needed assessment of the ear, or both. (3) Clinicians should assess the patient with cerumen impaction by history and/or physical examination for factors that modify management, such as ≥1 of the following: anticoagulant therapy, immunocompromised state, diabetes mellitus, prior radiation therapy to the head and neck, ear canal stenosis, exostoses, and nonintact tympanic membrane. (4) Clinicians should not routinely treat cerumen in patients who are asymptomatic and whose ears can be adequately examined. (5) Clinicians should identify patients with obstructing cerumen in the ear canal who may not be able to express symptoms (young children and cognitively impaired children and adults), and they should promptly evaluate the need for intervention. (6) Clinicians should perform otoscopy to detect the presence of cerumen in patients with hearing aids during a health care encounter. (7) Clinicians should treat, or refer to a clinician who can treat, the patient with cerumen impaction with an appropriate intervention, which may include ≥1 of the following: cerumenolytic agents, irrigation, or manual removal requiring instrumentation. (8) Clinicians should recommend against ear candling for treating or preventing cerumen impaction. (9) Clinicians should assess patients at the conclusion of in-office treatment of cerumen impaction and document the resolution of impaction. If the impaction is not resolved, the clinician should use additional treatment. If full or partial symptoms persist despite resolution of impaction, the clinician should evaluate the patient for alternative diagnoses. (10) Finally, if initial management is unsuccessful, clinicians should refer patients with persistent cerumen impaction to clinicians who have specialized equipment and training to clean and evaluate ear canals and tympanic membranes. The panel offered the following as options: (1) Clinicians may use cerumenolytic agents (including water or saline solution) in the management of cerumen impaction. (2) Clinicians may use irrigation in the management of cerumen impaction. (3) Clinicians may use manual removal requiring instrumentation in the management of cerumen impaction. (4) Last, clinicians may educate/counsel patients with cerumen impaction or excessive cerumen regarding control measures.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Schwartz SR, Magit AE, Rosenfeld RM, et al. Clinical Practice Guideline (Update): Earwax (Cerumen Impaction). Otolaryngol Head Neck Surg. 2017. PMID: 28045591. doi:10.1177/0194599816671491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。